Posts Categorized: Opioids

The following updates are from the Drug Policy Alliance. Thought you might enjoy hearing about positive progress. The Rohrabacher-Blumenauer Amendment, which prevents the Justice Department from using federal funds to interfere with state medical marijuana programs, was approved until December 22, when federal spending will be revisited. (The legislation was tacked onto the federal funding…

Did you watch the 60 Minutes segment about the opioid crisis on October 15th, 2017? In case you missed it, 60 Minutes correspondent Bill Whitaker interviewed ex-DEA Agent Joe Rannazzisi, who ran the DEA’s Office of Diversion Control that regulates and investigates the pharmaceutical industry. Rannazzisi, a whistleblower, said the opioid crisis was allowed to…

Recently New Jersey Senator Cory Booker introduced legislation called the Marijuana Justice Act of 2017. If the bill passes it will legalize marijuana at the federal level, incentivize legalization at the state level, and retroactively apply to those serving time in federal prison for marijuana-related offenses by providing a process for expungement and resentencing, pending…

On Thursday, July 27th, 2017 the Senate Appropriations Committee renewed an amendment which protects medical marijuana from federal interference. In other words, marijuana patients and providers cannot be prosecuted. The amendment had bipartisan support and passed with voice votes–which are used for non-controversial issues. The next step is for the amendment to be included in the final appropriations bill,…